AT&T Receives Frost & Sullivan’s 2025 Global Market Leadership Recognition for Passenger Vehicle Connectivity
Frost & Sullivan applauds AT&T's global market leadership in passenger vehicle connectivity,…
Index Exchange Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Leadership in Supply-Side Platforms
Index Exchange earns acclaim for advancing innovation, transparency, and customer-centric solutions within…
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
September 16, 2025 17:10 ET | Source: Theratechnologies MONTREAL, Sept. 16, 2025…
BioCatch Receives Frost & Sullivan’s 2025 Global Competitive Strategy Leadership Recognition for Excellence in Fraud Detection and Prevention
This recognition underscores BioCatch's strategic focus on fraud detection and prevention for the…
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres
Broadened indication increases access to liver cancer treatment across Europe and CE-marked…
MG 3 receives four stars but suffers rare and serious seat failure in Euro NCAP crash test
LEUVEN, BELGIUM – For decades, MG’s catchy slogan was ‘Safety Fast’ as…
Sanas Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Leadership in Accent Translation Solutions
Commitment to inclusivity, innovation, and customer experience positions Sanas as a category-defining…
Singtel Receives Frost & Sullivan’s 2025 Singapore and Southeast Asia Company of the Year Recognitions for Leadership in Managed SD-WAN & SASE, IoT Connectivity, and Quantum-Safe Networking
Singtel earns triple recognition for its innovation, execution, and customer-first approach in…
Tech Mahindra Receives Frost & Sullivan’s 2025 Asia-Pacific Technology Innovation Leadership Recognition in Business Process Management
Tech Mahindra redefines digital transformation through AI innovation and a customer-centric approach…
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for…